Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Detection of the 2019 Novel Coronavirus (SARS-CoV-2) Using Breath Analysis - Feasibility Study

NCT04602871 is registered in ClinicalTrials.gov with Scentech Medical Technologies Ltd as lead sponsor.

NCT NCT04602871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04602871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Detection of the 2019 Novel Coronavirus (SARS-CoV-2) Using Breath Analysis - Feasibility Study
Lead sponsor
Scentech Medical Technologies Ltd
Phase
Not applicable
Overall status
Completed
Start date
July 3, 2020
Completion date
January 30, 2021
Enrollment
54 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid19